Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Modus Therapeutics Announces Positive Topline Data from its Phase 1b LPS Provocation Study Evaluating the Potential of Sevuparin for Treatment of Sepsis
Modus Therapeutics, a company developing innovative treatments for patients with major unmet medical needs, announces […]
Malaysian Genomics to Offer World's First DNA-Driven Fertility Test
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the […]
C4XD and Garvan Institute of Medical Research Report Successful Patient Stratification Approach Using C4XD's New Precision Medicine Platform PatientSeek
C4X Discovery Holdings (C4XD), a pioneering Drug Discovery company, announces the launch of a precision […]
ValGenesis and Enterey Partner to Deliver a Better Consulting Experience for Life Sciences Companies Going Digital
ValGenesis, the market leader in enterprise Validation Lifecycle Management Systems (VLMS), and Enterey, a specialist […]
Mezzion Pharma Submits Protocol for Confirmatory Pivotal Phase 3 Trial ("FUEL-2") in Fontan Subjects
Mezzion Pharma has submitted a confirmatory pivotal Phase 3 Clinical Trial in Fontan subjects to […]
ObvioHealth Announces Ground-Breaking Digital Therapeutics API to Capture More Accurate Efficacy and Adherence Data in Clinical Trials
ObvioHealth, a pioneering virtual research organization, announces the launch of a proprietary application programming interface […]
Vysioneer Announces Data Sharing Agreement with Pfizer to Augment Oncology Clinical Trials with Artificial Intelligence
Vysioneer, a pioneer in AI for Oncology, today announced a data-sharing agreement with Pfizer, a […]
Neurophth Completes Patient Enrollment for Phase III clinical trial for the Gene Therapy treatment of LHON
Neurophth Therapeutics announced today that the last patient has been enrolled in the Phase III […]
FDA Accepts Orasis Pharmaceuticals' New Drug Application for CSF-1 for the Treatment of Presbyopia
Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on developing a unique eye drop to […]
Ewa Weglinska, Avery Dennison, on Sustainability in the Pharmaceutical Industry
In the video, Ewa Weglinska, Product Manager Pharmaceuticals, at Avery Dennison, talks about the importance […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more